#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Giant cell tumour of tendon sheath Follicular lymphoma stage III Oesophageal carcinoma Solitary fibrous tumour Acute myeloid leukaemia Haemolytic uraemic syndrome HER2 gene amplification Germ cell cancer Rhabdomyosarcoma Renal cell carcinoma Pleural mesothelioma malignant Liposarcoma Chronic graft versus host disease in intestine Kaposi's sarcoma Cataract More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Diagnostics Chondrosarcoma metastatic – Life with Disease Antisynthetase syndrome – Diagnostics Langerhans’ cell histiocytosis – Trials in Disease Progressive multifocal leukoencephalopathy Hypereosinophilic syndrome – Trials in Disease Krabbe’s disease – Treatment Hereditary angioedema – Diagnostics Adrenocortical carcinoma – Trials in Disease Basal cell naevus syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tucatinib Teriflunomide Pentixafor Gallium Ga-68 Vonicog Alfa Dolutegravir 68Ga-Dpi-4452 Treprostinil Palmitil Iptacopan Img-007 GRISNILIMAB SETARITOX Sparsentan Fulvestrant Acetylcysteine Amide Tobevibart Regn7257 Phosphocreatine Sodium Specific Nucleic Acid Sna-Xfsb Temsirolimus Nalbuphine Hydrochloride Docetaxel More therapies…

    Learn about Your Condition

    Epiphysiolysis Synovitis Bronchostenosis Epilepsy Noonan syndrome Hepatitis D Medullary thyroid cancer Colon cancer stage III Cholestatic pruritus BK virus infection Renal cell carcinoma stage IV Laryngeal cancer stage II Anal abscess Splenic marginal zone lymphoma Fungal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac amyloidosis

  • Study on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Czechia France Germany Italy The Netherlands Portugal +1

  • Study on the Effects and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Alxn2220
    France Germany The Netherlands Spain

  • Study on How Tafamidis is Absorbed in the Blood of Healthy Adults with Transthyretin Amyloid Cardiomyopathy

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Tafamidis
    Belgium

  • Study to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Vutrisiran
    Austria Belgium Czechia Denmark France Italy +5

  • Study on the Use of Flutemetamol (18F) for Diagnosing Cardiac Amyloidosis in Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Flutemetamol (18F)
    Italy

  • Study of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Patisiran
    Belgium Czechia Denmark France Italy The Netherlands +2
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!